Condition
Malignant Epithelial Mesothelioma|Adenocarcinoma of the Pancreas|Carcinoma, Non-Small-Cell Lung|Adenocarcinoma of the Ovaries
Estimated Enrollment: 17
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: VAC07001
Study First Received: December 22, 2007
Last Updated: February 19, 2009
Estimated Primary Completion Date: February 2009
Primary Outcome Measures:
Dose-limiting toxicities related to the investigational agent
Sponsors and Collaborators:
Anza Therapeutics, Inc.
Website Link: https://ClinicalTrials.gov/show/NCT00585845
